> A federal court has ruled that Illumina must pay Affymetrix $16.7 million for violating five patents involving genetic variation analysis. Report
> Cytyc will restate 10 years of financial statements. Report
> Neose Technologies has been cleared by the FDA to commence clinical trials for NE-180 in the United States. Release
> Napo Pharmaceuticals has received approval from the principal independent review board overseeing the Phase III study of crofelemer for diarrhea in people living with HIV/AIDS. Release
> Cambridge, MA-based Curis has selected the first development candidate from its Targeted Cancer Drug Development Platform. Release
And Finally… Don't schedule your heart attack for a weekend. A new study shows that mortality rates on heart attacks climbs from a weekday average of 12 percent to 12.9 percent on the weekend. Article